Sequence

Wegovy Maker Sues Wellness Clinics, Spas Over Counterfeit Weight-Loss Drugs

Novo Nordisk has filed lawsuits against wellness clinics and spas for selling non-FDA-approved versions of its weight-loss drugs.

The Rise of Weight-Loss Medications: Are Diet Companies Doomed?

While body positivity was popular in recent years, the pendulum seems to have swung the other way with the rise of weight-loss medications.

Shrinking Waists, Sizable Earnings: Weight-Loss Drug Market Estimated at $100 Billion by 2030

According to Barclays, the weight-loss drug industry could even climb as high as $200 billion within the next decade.

WeightWatchers’ Stock Surges After Obesity Drug Deal

WeightWatchers has acquired Sequence, a telehealth provider that gives users access to diabetes and weight loss drugs.